Global Triamcinolone Acetonide Topical Market Size, Share and Trends Analysis Report, By Type (Cream, Lotion, Ointment, and Spray), By Application (Eczema, Psoriasis, Dermatitis, and Others), and By Distribution Channel (Hospitals, Drug Stores, and Others), Forecast (2022-2028)

The global triamcinolone acetonide topical market is anticipated to grow at a significant CAGR during the forecast period 2022-2028. The growth of the market is attributed to the rising prevalence of skin diseases, increasing demand for minimally invasive procedures, and growing awareness about available treatment options. The increasing prevalence of skin diseases is one of the major factors driving the growth of this market. As per the data released pot survey conducted by the Department of Health and Family Welfare, in February 2022, around 23% people out of the total population in India are suffering from dandruff, followed by acne prevailing at around 11.9%. Dandruff and acne are two major skin diseases across the country, which in turn is bolstering the demand and consumption of triamcinolone acetonide. It is a synthetic corticosteroid that is used for the treatment of various skin diseases.

Furthermore, the triamcinolone acetonide topical is a type of medication which is used to treat various types of different medical conditions including eczema, psoriasis, and arthritis. Thus, the rising incidence of types of arthritis across the emerging nations such as India and China among other due to the presence of elderly population, is expected to further propel the growth of the market. According to the World Health Organization, around 26.1 million people in China had osteoarthritis in 1990, and this number increased to 61.2 million in 2019. The age-standardized prevalence of osteoarthritis increased from 2.9% in 1990 to 3.1% in 2019.

Some major players in the market include G&W laboratories Inc., Lannett Co. Inc., Perrigo Co. PLC, Taro Pharmaceutical Industries Ltd., Mylan NV, Lupin Inc., and Teva Pharmaceutical Industries Ltd. among others. The market players are helping significantly in the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay in the competition of the market. For instance, in April 2019, Encore Dermatology Inc. announced that it has acquired rights for SERNIVO (betamethasone dipropionate) Spray, 0.05%, as well as rights to market and distribute TRIANEX 0.05% (Triamcinolone Acetonide Ointment, USP) and PROMISEB Topical Cream in the US from Dr Reddy’s Laboratories Ltd., through its wholly owned subsidiary Promius Pharma LLC.

Market Coverage

• The market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- G&W laboratories Inc., Lannett Co. Inc., Perrigo Co. PLC, Taro Pharmaceutical Industries Ltd., Mylan NV, Lupin Inc. and Teva Pharmaceutical Industries Ltd. among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Triamcinolone Acetonide Topical Market Report by Segment

By Type

• Cream
• Lotion
• Ointment
• Spray

By Application

• Eczema
• Psoriasis
• Dermatitis
• Others

By Distribution Channel

• Hospitals
• Drug Stores
• Others

Global Triamcinolone Acetonide Topical Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa